Zydus receives Orphan Drug Designation from US FDA for malaria treatment EP News Bureau Dec 16, 2021 The Orphan Drug Designation provides up to seven years of marketing exclusivity in the US
Ganaplacide/lumefantrine combination show positive results in children with malaria EP News Bureau Sep 30, 2021 The combination, in the phase-IIb study conducted by Novartis and MMV, has the potential not only to clear malaria infection,…
